Late-stage lung cancer patients may have new hope with a promising new drug that is currently under clinical study.
A NEW drug can help advanced lung cancer patients live longer, and may aid in treating other kinds of cancer, researchers said on Monday.
If the initial results are confirmed in a Phase III clinical study already underway, it would be the first treatment developed in the past decade that can improve outcomes for patients with late-stage lung cancer.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
